<DOC>
	<DOCNO>NCT00057135</DOCNO>
	<brief_summary>This randomize controlled trial examine effectiveness pharmacy-based intervention design improve adherence antipsychotic medication among patient serious mental illness .</brief_summary>
	<brief_title>Improving Antipsychotic Adherence Among Patients With Serious Mental Illness</brief_title>
	<detailed_description>Background : Anti-psychotic medication essential component treatment patient schizophrenia . Unfortunately , pharmacy data indicate 40 % VA patient schizophrenia poorly adherent antipsychotic . These patient much great risk hospitalization . Objectives : We examine effectiveness practical , pharmacy-based intervention improve antipsychotic adherence among patient serious mental illness ( SMI ) . Specifically , examine whether pharmacy-based intervention increase antipsychotic medication adherence patient satisfaction care decrease psychiatric symptom , inpatient utilization . We also examine relative effectiveness pharmacy-based intervention among patient vary : ) degrees cognitive limitation , b ) degree insight illness , c ) attitudes towards medication . Methods : Using pharmacy administrative data , identify patient schizophrenia , schizoaffective disorder , severe bipolar disorder require antipsychotic medication poor antipsychotic adherence previous year . Patients must complete least two outpatient psychiatric visit one study site . Patients randomize : 1 ) usual care ; 2 ) Pharmacy Based intervention . The pharmacy-based intervention consist usual care plus : 1 ) `` unit-of-use '' adherence packaging ; 2 ) patient education session ; 3 ) refill reminder ; 4 ) clinician notification miss fill . In-person patient assessment conduct baseline , 6 month , 12 month follow randomization . Medical record administrative data collect baseline , 6 month , 12 month , 18 month follow randomization . The primary outcome measure medication adherence measure medication possession ratio adherence category combine pharmacy information patient self-report antipsychotic blood level . Patientsï¿½ level psychiatric symptom , quality life , satisfaction secondary outcome measure . In supplemental analysis , compare effectiveness pharmacy-based intervention among subgroups patient vary degree cognitive limitation , insight illness , attitude towards antipsychotic medication . Findings : One hundred fifty patient enrol study . Follow-up rate high , 90 % patient complete 6 month follow assessment 80 % complete 12 month assessment . In person follow visit complete . Findings regard accuracy administrative diagnosis schizophrenia , accuracy pharmacy data identify patient poor adherence , patient factor associate study recruitment present national meeting . Main study analyse ongoing . 6 . Status : Enrollment inperson-patient follow complete . Study analyse progress . Impact : Improving adherence among SMI patient critical improve outcomes . This study examine effectiveness practical , low-cost intervention vulnerable patient .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Patients must adult veteran . Diagnosis schizophrenia , schizoaffective disorder , bipolar disorder . At least one active oral antipsychotic prescription . History poor medication compliance . Have receive depot antipsychotic last year . Have supervise medication administration . Have attend VA outpatient appointment past 6 month , none schedule , . Are prescribed Clozapine . Have fatal illness life expectancy le 2 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Treatment Refusal</keyword>
	<keyword>Drug Packaging</keyword>
	<keyword>Reminder Systems</keyword>
	<keyword>Antipsychotic Agents</keyword>
</DOC>